Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.


Latest Press Releases

CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness
Healthcare & PharmaceuticalProduct Announcements

CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness

February 26, 2026 8:30 AM

CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in proven, science-backed natural ingredients and products, today announced the launch of Empowr, a plant-based protein and creatine powder for everyday adults looking to increase daily protein intake for overall wellness. "Empowr" represents a dynamic evolution in functional nutrition," said Joseph Dowling,...

Read more
Black Book Research Releases
Healthcare & PharmaceuticalProduct Announcements

Black Book Research Releases "France: State of Acute Care EHR and Digital Health 2026"

February 26, 2026 8:15 AM

Black Book Market Research today announced the publication of France: State of Acute Care EHR and Digital Health 2026 a qualitative market report intended to support hospital executives, CIO/DSI leadership, clinical informatics teams, and procurement stakeholders evaluating acute-care DPI/EHR modernization and replacement programs for the 2026-2030 planning horizon. The France edition reviews doctrine-aligned interoperability requirements,...

Read more
Umbrella Labs Announces GLP-3R, The New Research Designation For Retatrutide, To Support High Rigor Tri-Receptor Endocrine Signaling Bench Science
Healthcare & PharmaceuticalCompany Update

Umbrella Labs Announces GLP-3R, The New Research Designation For Retatrutide, To Support High Rigor Tri-Receptor Endocrine Signaling Bench Science

February 26, 2026 7:15 AM

Umbrella Labs today announced an updated research catalog standard that formally presents GLP-3R as the internal research designation for retatrutide, also identified as LY-3437943, supplied as a lyophilized peptide vial for laboratory developmental research use only. This program is designed for laboratories building reproducible tri-receptor signaling studies where naming clarity, lot traceability, and documentation readiness directly impact...

Read more
IRLAB Secures Milestone Payment for First Patient Dosed in Phase Ib Study with IRL757 in Parkinson's Disease
Healthcare & PharmaceuticalRegulatory

IRLAB Secures Milestone Payment for First Patient Dosed in Phase Ib Study with IRL757 in Parkinson's Disease

February 26, 2026 6:15 AM

IRLAB Therapeutics AB (STO:IRLAB-A)(FRA:6IRA), a company focused on discovering and developing new treatments for Parkinson's disease, today announces that the first patient has been dosed in a Phase Ib study with IRL757 - a potential new treatment for Parkinson's disease-related apathy. This event triggers a USD 3 million milestone payment to IRLAB, payable in instalments in 2026. The study is fully funded by IRLAB's development collaborator,...

Read more
AlzeCure Publishes its Year-End Report for January - December 2025
Healthcare & PharmaceuticalEarnings

AlzeCure Publishes its Year-End Report for January - December 2025

February 26, 2026 2:25 AM

AlzeCure Pharma AB (publ) (STO:ALZCUR)(FRA:AC6) today announced that its Year-end report for the period January - December 2025 is now available on the company's website: www.alzecurepharma.com/en/section/investors/financial-reports/ "We had a positive and active fourth quarter of 2025. During the quarter, our focus was on preparing the Phase II study in Alzheimer's patients with NeuroRestore ACD856, for which we were awarded a grant of EUR 2.5...

Read more
Maximus GLP-1 Weight Loss (2026): Pricing, Protocols, Compounding Facts, and What to Verify Before You Start
Healthcare & PharmaceuticalAdvertorial

Maximus GLP-1 Weight Loss (2026): Pricing, Protocols, Compounding Facts, and What to Verify Before You Start

February 25, 2026 6:00 PM

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Testosterone replacement therapy, GLP-1 medications, and other prescription treatments require evaluation by qualified healthcare professionals. Always consult a qualified healthcare professional before starting any prescription treatment. This article contains affiliate links. If you purchase through these links, a commission may be earned at no...

Read more
CORRECTION: Protagonist Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Healthcare & PharmaceuticalEarnings

CORRECTION: Protagonist Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

February 25, 2026 5:15 PM

Protagonist Therapeutics (Nasdaq:PTGX) ("Protagonist" or "the Company") today reported financial results for the fourth quarter and full year ended December 31, 2025 and provided a corporate update. "In 2025, Protagonist reached new heights with multiple successful Phase 3 outcomes and two NDA filings of our partnered assets, ICOTYDE and rusfertide," said Dinesh V. Patel, Ph.D., the Company's President and CEO. "We see the next 12 to 24 months...

Read more
Protagonist Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Healthcare & PharmaceuticalCompany Update

Protagonist Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

February 25, 2026 4:05 PM

Protagonist Therapeutics (Nasdaq:PTGX) ("Protagonist" or "the Company") today reported financial results for the fourth quarter and full year ended December 31, 2025 and provided a corporate update. "In 2025, Protagonist reached new heights with multiple successful Phase 3 outcomes and two NDA filings of our partnered assets, ICOTYDE and rusfertide," said Dinesh V. Patel, Ph.D., the Company's President and CEO. "We see the next 12 to 24 months...

Read more
DirectTrust and CARIN Alliance Announce CARIN-CFA Accreditation Recognized by CMS as Evaluation Pathway for Participation in the Medicare App Library
Healthcare & PharmaceuticalCompany Update

DirectTrust and CARIN Alliance Announce CARIN-CFA Accreditation Recognized by CMS as Evaluation Pathway for Participation in the Medicare App Library

February 25, 2026 2:45 PM

DirectTrust®, a non-profit healthcare industry alliance focused on furthering trust in health technology and data exchange through standards, accreditation, and other services, and the CARIN Alliance, a multi-stakeholder collaborative dedicated to empowering consumers and their authorized caregivers to easily get, use, and share their digital health information when, where, and how they want to in order to achieve their goals, today announced...

Read more
VRCCO Invests in the Future of Veterinary Medicine Through Education-Driven Innovation
Healthcare & PharmaceuticalCompany Update

VRCCO Invests in the Future of Veterinary Medicine Through Education-Driven Innovation

February 25, 2026 2:15 PM

As the veterinary profession faces increasing demands, rapid medical advances, and nationwide workforce shortages, the Veterinary Referral Center of Central Oregon (VRCCO) is taking a proactive approach by strengthening the future of veterinary medicine through continuous education and hands-on professional development. Through expanded learning initiatives including a Virtual Radiation Safety Course, the 2026 Spring Symposium, and robust...

Read more
The National Children's Cancer Society Earns Platinum Seal of Transparency from Candid
Healthcare & PharmaceuticalCompany Update

The National Children's Cancer Society Earns Platinum Seal of Transparency from Candid

February 25, 2026 1:20 PM

The National Children's Cancer Society (NCCS) is proud to announce it has earned the Platinum Seal of Transparency from Candid, the highest level of recognition awarded to nonprofit organizations for openness and accountability. The Platinum Seal of Transparency is granted to organizations that publicly share detailed information about their mission, strategies, capabilities, achievements, and measurable impact. This distinction places the NCCS...

Read more
Lawrence
Healthcare & PharmaceuticalCompany Update

Lawrence "Larry" Waldman Calls for Stronger Action Against Healthcare Fraud

February 25, 2026 11:45 AM

Lawrence "Larry" Waldman, President of Cyberhealth AI and founder of Ai Health Technologies, Inc., is raising awareness about the growing impact of healthcare provider fraud and the urgent need for better prevention tools across Medicare and commercial insurance systems. Healthcare fraud is a costly and widespread issue in the United States. According to the National Health Care Anti-Fraud Association (NHCAA), healthcare fraud is estimated to...

Read more
Crystal Cove Recovery, a Laguna Beach Addiction Treatment Center, Collaborates with Intervention On Call for Strategic Site Visit
Healthcare & PharmaceuticalPartnerships

Crystal Cove Recovery, a Laguna Beach Addiction Treatment Center, Collaborates with Intervention On Call for Strategic Site Visit

February 25, 2026 11:00 AM

Crystal Cove Recovery, a premier addiction treatment center in Laguna Beach, California, is pleased to announce the successful completion of a collaborative site visit and dinner with Intervention On Call, a national crisis intervention service supporting families and treatment providers navigating complex addiction and mental health cases. The event was designed to strengthen coordination between crisis intervention and residential treatment,...

Read more
Four Borland Groover Ambulatory Surgery Centers Named Among Best ASCs by U.S. News & World Report
Healthcare & PharmaceuticalAwards

Four Borland Groover Ambulatory Surgery Centers Named Among Best ASCs by U.S. News & World Report

February 25, 2026 10:00 AM

U.S. News & World Report has released its inaugural ratings of the nation's top ambulatory surgery centers, naming four Borland Groover facilities among this year's high performers in the colonoscopy and endoscopy category. The recognized centers include Orange Park Endoscopy Center, Jacksonville Center for Endoscopy Riverside, Jacksonville Center for Endoscopy Southside and St. Augustine Endoscopy Center. In 2024, U.S. News launched its...

Read more
CASI Pharmaceuticals Receives the Delisting Decision From the Nasdaq Hearings Panel
Healthcare & PharmaceuticalExchange Listing Upgrade

CASI Pharmaceuticals Receives the Delisting Decision From the Nasdaq Hearings Panel

February 25, 2026 9:00 AM

CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused on developing CID-103, a potential best-in-class, anti-CD38 monoclonal antibody for patients with organ transplant rejection and autoimmune diseases, today announced that it has received a determination letter from the Hearings Panel (the "Panel") of The Nasdaq Stock Market ("Nasdaq") dated February 23, 2026, notifying the Company that the Panel...

Read more
Aspire Biopharma's Buzz Bomb(TM) Caffeine Company Achieves Record Social Media Growth and Sales Surge Following World-Record Marathon Sponsorship
Healthcare & PharmaceuticalProduct Announcements

Aspire Biopharma's Buzz Bomb(TM) Caffeine Company Achieves Record Social Media Growth and Sales Surge Following World-Record Marathon Sponsorship

February 25, 2026 8:30 AM

Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), today announced a massive expansion of its social media and digital marketing footprint for its wholly owned subsidiary, Buzz Bomb Caffeine Company. The initiative follows a successful strategic rebranding and a high-profile sponsorship of professional ultra-marathoner Ashley Paulson, whose recent world-record performance catalyzed a significant increase in brand...

Read more
Duly Surgeon First in Illinois to Use Tumor-Illuminating Technology for Ovarian Cancer Surgery
Healthcare & PharmaceuticalCompany Update

Duly Surgeon First in Illinois to Use Tumor-Illuminating Technology for Ovarian Cancer Surgery

February 25, 2026 8:00 AM

Duly Health and Care this month announced that Dr. Sameer Sharma, a gynecologic oncologist at Duly Health and Care's Chicagoland med­ical group, DuPage Medical Group, Ltd., is the first physician in Illinois to perform ovarian cancer surgery using Cytalux, a newly approved imaging agent that causes cancerous tissue to "glow" - and can thus help surgeons see and remove tumors with greater precision. "Ovarian cancer surgery often comes down to...

Read more
Burst Raises $3M To Help Retailers Maximize FSA/HSA Spend While Lowering Consumer Health Costs
Healthcare & PharmaceuticalFinancing

Burst Raises $3M To Help Retailers Maximize FSA/HSA Spend While Lowering Consumer Health Costs

February 25, 2026 8:00 AM

Burst (formerly Float), the healthcare payments platform that helps retailers and wellness brands unlock billions in untapped FSA and HSA spending, today announced it has raised $3 million in total funding, including a $2.1 million seed round led by Pear VC with participation from Rock Health Capital, Alumni Ventures, and others. The capital will accelerate product development and fuel partnerships with retailers, e-commerce brands, and plan...

Read more
Ensysce Biosciences Initiates Review of Strategic Alternatives to Enhance Shareholder Value
Healthcare & PharmaceuticalCompany Update

Ensysce Biosciences Initiates Review of Strategic Alternatives to Enhance Shareholder Value

February 25, 2026 8:00 AM

Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for novel therapeutics while reducing the potential for abuse and overdose, today announced its Board of Directors has initiated a formal review of a broad range of strategic alternatives intended to enhance shareholder value and support the continued advancement of the Company's proprietary technologies....

Read more
Zomedica Expands Distribution of TRUVIEW(R) Digital Microscopy Platform Through National Agreement with Moichor, a Leader in Veterinary Pathology
Healthcare & PharmaceuticalCompany Update

Zomedica Expands Distribution of TRUVIEW(R) Digital Microscopy Platform Through National Agreement with Moichor, a Leader in Veterinary Pathology

February 25, 2026 6:30 AM

Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative diagnostic and therapeutic products for equine and companion animals, today announced a commercial distribution agreement with Moichor, a recognized leader in veterinary reference and point-of-care laboratory services across the United States. Under the agreement, in addition to Zomedica's own direct placements of TRUVIEW systems in the...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers • June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?